Pro-angiogenic Molecules for Therapeutic Angiogenesis

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Vascular Biology

Background:

• Therapeutic angiogenesis aims to stimulate neovascularization in ischemic tissues.
• Conventional methods utilize proangiogenic factors to induce angiogenesis.
• This review explores various proangiogenic factors for tissue repair.

Purpose of the Study:

• To provide a comprehensive overview of therapeutic angiogenesis.
• To highlight the role of diverse proangiogenic factors (growth factors, peptides, small molecules, polysaccharides) in neovascularization.
• To identify current challenges and future directions in the field.

Main Methods:

• A systematic literature search was conducted focusing on therapeutic angiogenesis and proangiogenic factors.
• Reviewed literature was qualitatively analyzed for relevance and detail.
• Content was organized into sections covering different categories of proangiogenic factors.

Main Results:

• 244 scientific literatures were reviewed to understand the significance of proangiogenic factors in revascularizing ischemic tissues.
• The review details recent advancements in proangiogenic factor applications for therapeutic angiogenesis.
• Key findings underscore the critical role of these factors in promoting blood vessel formation.

Conclusions:

• Various proangiogenic factors are crucial for therapeutic angiogenesis.
• A significant gap exists in defined delivery systems for proangiogenic growth factors in clinical settings.
• Developing biomaterial-based delivery paradigms is essential for advancing the clinical application of therapeutic angiogenesis.